OXE Receptors Given that PDE5 inhibitors are commonly used in patients with ED and PH, our findings may have significant clinical implications in alerting physicians of putative adverse effect of PDE5 inhibitors tuskonus May 7, 2026
OXE Receptors It should be noted that mAbs with the highest binding signals for the peptide in a standard ELISA have very weak or no binding to cell-surface associated GPC3 (data not shown) tuskonus December 17, 2024